Accession Number: | 0001127602-23-004134 |
Date: | 2023-02-07 |
Issuer: | LABORATORY CORP OF AMERICA HOLDINGS (LH) |
Original Submission Date: |
KONG GARHENG
531 SOUTH SPRING STREET
BURLINGTON, NC 27215
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNIT | 0.0 | 2023-02-07 | deemed execution date | A | 849 (a) | common stock 849 | $0.00 | 1,591 | direct |
ID | footnote |
---|---|
f1 | each restricted stock unit represents the contingent right to receive one share of laboratory corporation of america holdings common stock. |
f2 | the restricted stock units vest fully on february 7, 2024. |
f3 | this number reflects the aggregate number of restricted stock units held by the reporting person. |